Question Number: 84
PDR Number: SQ22-000439
Date Submitted: 10/11/2022
Department or Body: Department of Health
A whole-body imaging study with a surrogate mRNA expressing luciferase protein encapsulated in the lipid nanoparticles used in the Pfizer vaccine indicated that the expressed protein was mainly localised at the injection site and distributed to liver. Spike protein expression was detected in antigen presenting cells in draining lymph nodes and spleen in mice after injection of the Moderna mRNA vaccine. The spike protein expressed by COVID-19 mRNA vaccines in blood circulation was not measured in nonclinical animal studies. In a recent publication, available at: https://academic.oup.com/cid/article/74/4/715/6279075, very low levels (in pg/mL) of a fragment (S1 subunit) of the spike protein were detected in the plasma of 11 out of 13 human subjects from one day to nine days after the first injection. The full-length spike protein was only detected in three out of 13 subjects from day nine to 29. The S1 protein rapidly disappeared, associated with the induction of anti-S1 and anti-spike antibodies. After the second vaccine dose, no S1 or spike protein was detected.